All PFN ARTICLES

GLP-1 drugs may have triggered America’s protein obsession, but the greater opportunity is emerging from a more disruptive change: consumers are beginning to buy and eat less. Food companies and supermarkets must now extract greater nutritional and commercial value from every mouthful.

Clinical evidence helps point the way. A randomised 3×3 crossover study, published in a peer-reviewed journal and indexed on PubMed, shows that adding avocado to a mixed meal can improve post-meal blood glucose response and satiety, particularly in overweight adults. For GLP-1 users, those outcomes are not theoretical, they map directly onto daily challenges around energy dips, under-eating and nutritional adequacy.